We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vertex Pharmaceuticals Inc | NASDAQ:VRTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.43 | 0.36% | 401.59 | 401.34 | 401.68 | 405.665 | 397.59 | 401.50 | 566,037 | 19:57:26 |
MASSACHUSETTS
(State or other jurisdiction of incorporation)
|
000-19319
(Commission File Number)
|
04-3039129
(IRS Employer Identification No.)
|
|
VERTEX PHARMACEUTICALS INCORPORATED
|
|
(Registrant)
|
|
|
Date: March 29, 2017
|
/s/ Michael J. LaCascia
|
|
Michael J. LaCascia
Senior Vice President, General Counsel and Corporate Secretary |
|
|
1 Year Vertex Pharmaceuticals Chart |
1 Month Vertex Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions